News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
3,244 Results
Type
Article (160)
Press Release (3084)
Section
Business (706)
Career Advice (6)
Deals (133)
Drug Development (386)
FDA (82)
Job Trends (109)
News (1429)
Policy (226)
Tag
Academia (19)
Allergies (2)
Alliances (200)
ALS (1)
Alzheimer's disease (6)
Antibody-drug conjugate (ADC) (1)
Approvals (106)
Autoimmune disease (1)
Best Places to Work (112)
Biotechnology (1)
Bladder cancer (2)
Breast cancer (11)
Cancer (52)
Cardiovascular disease (17)
Career advice (6)
CAR-T (2)
Cell therapy (3)
Clinical research (387)
Collaboration (8)
COVID-19 (5)
CRISPR (1)
C-suite (1)
Data (87)
Diabetes (7)
Diagnostics (5)
Drug discovery (2)
Drug pricing (1)
Earnings (277)
Events (375)
Executive appointments (2)
FDA (120)
Frontotemporal dementia (2)
Funding (5)
Gene editing (1)
Gene therapy (2)
GLP-1 (5)
Government (36)
Guidances (2)
Healthcare (67)
IgA nephropathy (2)
Indications (5)
Infectious disease (7)
Inflammatory bowel disease (7)
Influenza (1)
Intellectual property (2)
Interviews (1)
IPO (59)
Job creations (11)
Job search strategy (5)
Layoffs (2)
Legal (40)
Liver cancer (1)
Lung cancer (10)
Lymphoma (5)
Medical device (23)
Medtech (23)
Mergers & acquisitions (75)
Metabolic disorders (12)
Multiple sclerosis (1)
Neuroscience (11)
NextGen: Class of 2026 (45)
Non-profit (12)
Obesity (5)
Opinion (2)
Parkinson's disease (1)
Patents (2)
Patient recruitment (1)
People (170)
Pharmacy benefit managers (1)
Phase 1 (56)
Phase 2 (96)
Phase 3 (247)
Pipeline (51)
Postmarket research (34)
Preclinical (26)
Prostate cancer (3)
Radiopharmaceuticals (1)
Rare diseases (3)
Real estate (22)
Regulatory (225)
Research institute (5)
RSV (1)
Spinal muscular atrophy (2)
Startups (20)
Vaccines (4)
Weight loss (4)
Women's health (1)
Date
Last 7 days (6)
Last 30 days (14)
Last 365 days (165)
2026 (17)
2025 (163)
2024 (193)
2023 (175)
2022 (199)
2021 (254)
2020 (394)
2019 (244)
2018 (177)
2017 (224)
2016 (151)
2015 (186)
2014 (134)
2013 (118)
2012 (116)
2011 (141)
2010 (96)
Location
Africa (1)
Arizona (2)
Asia (153)
Australia (21)
California (31)
Canada (12)
China (5)
Colorado (2)
Delaware (8)
Europe (865)
Idaho (1)
Illinois (10)
Japan (10)
Maryland (3)
Massachusetts (22)
New Jersey (31)
New York (4)
North Carolina (2)
Northern California (22)
Ohio (1)
Pennsylvania (1)
South America (6)
Southern California (6)
Texas (1)
United States (118)
Wyoming (1)
3,244 Results for "epa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Battelle Awarded U.S. EPA STREAMS V Contract to Deliver Nationwide Scientific, Technical, Research, Engineering, and Modeling Support
February 6, 2026
·
2 min read
Press Releases
HLS Therapeutics and Amarin Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 15, 2025
·
4 min read
Press Releases
Amarin and HLS Therapeutics Collaborate on Presenting REDUCE-IT® and EPA Mechanistic Data at the Canadian Cardiovascular Congress
October 15, 2025
·
9 min read
Press Releases
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
September 1, 2025
·
10 min read
Press Releases
Amarin To Present New Analyses Affirming Robustness of Data from REDUCE-IT and Additional Mechanisms of Action of Eicosapentaenoic Acid (EPA) at American Heart Association (AHA) Scientific Sessions 2025
November 4, 2025
·
8 min read
Press Releases
New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2025
August 25, 2025
·
10 min read
Pharm Country
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24
Amarin Corporation plc highlighted three data presentations at ACC.24 showcasing the mechanistic activity of Eicosapentaenoic acid, including the potential effects of EPA on endothelial cell dysfunction and on oxidation of samples enriched with Lp.
April 8, 2024
·
12 min read
Pharm Country
Steel Jupiter’s Indoor Air Innovation Receives EPA Device Determination
Steel Jupiter has achieved a major development milestone with the recent issuance of a device determination from the U.S. Environmental Protection Agency (EPA) for the company’s unique and innovative “Zinnia Technology-Coated MERV 8 Air Filter.”
February 20, 2024
·
3 min read
Press Releases
Amarin Highlights Recent Data Presented at ACC.25 Evaluating Mechanistic Effects of Eicosapentaenoic Acid (EPA) in Lp(a)-Enriched Plasma and in Combination with GLP-1 Agonist
April 1, 2025
·
13 min read
Genetown
GreenLight Biosciences Secures EPA Registration for New Bioinsecticide, Calantha, Historic Step Towards A Safer and More Sustainable Food System
GreenLight Biosciences (GreenLight Bio) has been granted registration by the U.S. Environmental Protection Agency (EPA) and several states for its groundbreaking Calantha™ product, designed to target and control the highly destructive Colorado potato beetle.
January 4, 2024
·
5 min read
1 of 325
Next
